Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia

Abstract

abstract. Hypercholesterolemia is one of the most representative disorders of the common diseases. To evaluate the prevalence of hypothyroidism in the population of adult hypercholesterolemia, we prospectively examined the thyroid function in patients with untreated or treated hypercholesterolemia as a multi-center survey. Subjects were the patients who were treated with some antilipemic agents or the untreated patients whose total cholesterol (TC) was over 220 mg/dL and/or LDL-cholesterol (LDL-C) over 140 mg/dL. Among 737 cases recruited, 725 cases (300 males and 425 females) participated in the survey including the thyroid function test. The patient's backgrounds include hypertension (51%), diabetes mellitus (49%), fatty liver (17%), smoking (15%), and habitual drinking (10%). The 72% of the patients were treated with some antilipemic agents and the mean values of TC, LDL-C, triglyceride (TG), HDL-cholesterol (HDL-C), and LDL-C/HDL-C ratio were 204.5 mg/dL, 119.6 mg/dL, 144.4 mg/dL, 60.7 mg/dL and 2.25, respectively. The primary hypothyroidism was seen in 27 cases (3.7%) (11 males, 16 females) with subclinical hypothyroidism in 17 cases (2.4%) and overt hypothyroidism in 10 cases (1.4%). The central hypothyroidism was seen in 4 cases (0.6%). The prevalence of hypothyroidism was 4.3% in patients with hypercholesterolemia. Taking account of the large number of patients with dyslipidemia and importance of avoiding unnecessary administration and associated adverse effects, evaluation of the thyroid function could be warranted in patients with dyslipidemia although cost-benefit issues waits further investigation.Key words: Hypercholesterolemia, Dyslipidemia, Subclinical hypothyroidism strongly related to atherosclerotic cardiovascular disease. Recently, new therapeutic reagents such as fibrates and statins have been created and primary dyslipidemia is effectively treated with these reagents [1]. However, they are not low priced and may induce rare but serious side effects such as rhabdomyolysis [1]. Hypothyroidism induces secondary hypercholesterolemia that increases the incidence of atherosclerotic cardiovascular events [2], and replacement of low-

Association and impact of non-alcoholic fatty liver disease on thyroid function

“…Our study would confirm the correlation between NAFLD and thyroid dysfunction and a correlation between the TSH level and triglycerides (P =0.003). These observations agree with the findings of other studies that suggest a correlation between hypothyroidism and hyperlipidemia (48,49). The increase in triglycerides in patients with hypothyroidism is explained by the reduced hepatic activity of triglyceride lipase (48,50) and increased fatty acid oxidation.…”

Should thyroid‐stimulating hormone goals be reviewed in patients with Type 1 diabetes mellitus? Results from The Brazilian Type 1 Diabetes Study Group

“…Lipid levels and blood pressure differences could also be responsible for the link between thyroid and diabetic complications. A lower thyroid function may increase cholesterol and blood pressure levels, which are well established risk factors for diabetes‐related chronic complications ; however, neither total or LDL cholesterol, systolic or diastolic blood pressure differed between groups in our study, which makes this hypothesis unlikely.…”

Lipid Profile and Electrocardiographic Changes in Thyroid Dysfunction

“…[17] In a multicentre study of prevalence of hypothyroidism in 752 hypercholesterolemic patients, primary hypothyroidism occurred in 3.7%. [15] The study by P Archana and K ashok showed a significant correlation between raised TSH levels and serum total cholesterol and LDL-cholesterol. [18] Hypothyroid patients have elevated atherogenic parameters and are at high risk for developing cardiovascular disorders.…”